Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (142)
  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (29)
  • Speech (21)
  • In the News (5)
  • Announcements (3)

Publication Type

  • Intelligence (72)
  • DEA Administrator (39)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (25)
  • Forensics (10)
  • Announcement (3)
  • Recruitment (1)

Drug Name

  • Narcóticos (opioides) (23)
  • Fentanyl (13)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Heroin (7)
  • Cannabis (5)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
340 Results - Showing 21 to 30
DOCUMENT
|
Publication

The Illegal Drug Threat in Wisconsin

Marzo 25, 2025
The most significant drug-related threat to Wisconsin is posed by Mexican drug trafficking organizations (DTO), particularly the Cartel de Sinaloa (CDS) and the Cartel de Jalisco Nueva Generación (CJNG). Mexican DTOs dominate the wholesale supply of illicit opioids (both fentanyl and heroin), cocaine, methamphetamine, and Mexico-grown marijuana in the state...
Marzo 25, 2025
DOCUMENT
|
Publication

Mexican Cartel Presence and Impact in Australia and New Zealand

Marzo 25, 2025
Mexican cartels, primarily the Sinaloa Cartel and Jalisco New Generation Cartel (CJNG), are increasingly targeting illicit drug markets in Australia and New Zealand. In collaboration with organized crime groups (OCGs) and money laundering organizations (MLOs) in Australia and New Zealand, cartels are capitalizing on the highly lucrative methamphetamine and cocaine...
Marzo 25, 2025
DOCUMENT
|
Publication

State and Territory Report on Enduring and Emerging Threats (October 2024)

Diciembre 30, 2024
Due to the similarities of medetomidine and dexmedetomidine to xylazine — medetomidine is used in a similar manner as xylazine in veterinary medicine, and dexmedetomidine in human practice and veterinary medicine — DEA assesses both drugs have the potential to be supplements to or replacements for xylazine in terms of...
Diciembre 30, 2024
DOCUMENT
|
Publication

Drogas de Abuso

Diciembre 19, 2024
La educación juega un papel esencial en la prevención del uso y el uso indebido de sustancias. Drogas de abuso, Una guía de recursos de la DEA está diseñada para ser una fuente confiable de información sobre las drogas de uso más común y uso indebido en Estados Unidos. Esta...
Diciembre 19, 2024
DOCUMENT
|
Publication

Drugs of Abuse 2024

Diciembre 12, 2024
Education plays a critical role in preventing substance use and misuse. Drugs of Abuse, A DEA Resource Guide, is designed to be a reliable resource on the most commonly used and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug...
Diciembre 12, 2024
DOCUMENT
|
Publication

The Illegal Drug Threat in Illinois

Diciembre 05, 2024
The most significant drug-related threat to Illinois is posed by Mexican drug trafficking organizations (DTOs), particularly the Cartel de Sinaloa (CDS) and the Cartel de Jalisco Nueva Generación (CJNG). Mexican DTOs dominate the wholesale supply of illicit opioids (fentanyl and heroin), cocaine, methamphetamine, and Mexico grown marijuana in the state.
Diciembre 05, 2024
DOCUMENT
|
Publication

The Illegal Drug Threat in Indiana

Diciembre 05, 2024
The most significant drug-related threat to Indiana is posed by Mexican drug trafficking organizations (DTO), particularly the Cartel de Sinaloa (CDS) and the Cartel de Jalisco Nueva Generación (CJNG). Mexican DTOs dominate the wholesale supply of illicit opioids (both fentanyl and heroin), cocaine, methamphetamine, and Mexico-grown marijuana in the state...
Diciembre 05, 2024
DOCUMENT
|
Publication

GUARDS – Qualitative Method Summary Sheet

Diciembre 03, 2024
This document is an internal Drug Enforcement Administration quality system document which provides a summary sheet for validated qualitative method (GUARDS). The document is updated periodically and is current as of March 11, 2024, and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been...
Diciembre 03, 2024
DOCUMENT
|
Announcements

DEA and HHS Extend Telemedicine Flexibilities through 2025

Noviembre 15, 2024
In 2023, in response to a set of proposed telemedicine rules, DEA received more than 38,000 comments and held two days of public listening sessions. In light of that feedback and discussion, and to give DEA time to consider a new path forward for telemedicine, DEA and the Department of...
Noviembre 15, 2024
DOCUMENT
|
DEA Administrator Remarks

Welcome Remarks at the 2024 DEA National Family Summit on Fentanyl

Noviembre 15, 2024
We are gathered here today because every single one of us has been impacted by fentanyl in our communities. This issue is not distant. It's personal. It's in our homes. It's in our neighborhoods. It's in our communities. And yet today we also have reason to feel hopeful about the...
Noviembre 15, 2024

Paginación

  • Primera página «
  • Anterior
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster